Leveraging international stakeholders' experiences with oral PrEP costs to accelerate implementation of the monthly dapivirine vaginal ring: A qualitative study
- PMID: 39587579
- PMCID: PMC11587620
- DOI: 10.1186/s12961-024-01240-5
Leveraging international stakeholders' experiences with oral PrEP costs to accelerate implementation of the monthly dapivirine vaginal ring: A qualitative study
Abstract
Background: Costing and financing systematic implementation are recognized barriers to human immunodeficiency virus (HIV) prevention. In the absence of empiric implementation and economic data, perspectives from international stakeholders involved in developing and supporting daily oral pre-exposure prophylaxis (PrEP) policy, and programs can provide critical insights for developing costed plans to support and accelerate the rollout of novel long-acting PrEP (LA-PrEP) methods, such as the monthly dapivirine vaginal ring (PrEP ring).
Methods: We interviewed stakeholders from purposively selected international organizations about anticipated PrEP-ring implementation costs, evidence gaps and key process steps for developing a costed rollout plan template (CRPT). We deductively analysed interviews.
Results: The 27 stakeholders (11 donors, 10 nongovernmental, 4 academic/research, 2 multilateral) identified 10 cost-related themes: 7 for planning and implementation and 3 for financing, costing and budgeting. Planning and implementation cost considerations included: (1) actionable target setting; (2) multilevel communication strategies for awareness-raising, demand creation, client-level adherence and choice counselling; (3) human resources, encompassing task shifting and integration into non-HIV services; (4) supply chain costs, including commodities, manufacturing diversification, packaging and forecasting; (5) laboratory infrastructure and monitoring; (6) updated health information systems and metrics to monitor and evaluate multiple methods integrated into HIV, non-HIV and de-medicalized delivery settings; and (7) technical assistance and knowledge management. Themes for financing, costing and budgeting comprised: (8) cost and budget analyses, such as cost-effectiveness; (9) economic evidence gaps on service integration; and (10) innovative or co-financing for sustainable and equitable allocation of limited financial resources to support accelerated PrEP-ring delivery. We organized these themes within the CRPT.
Conclusions: The CRPT could expedite planning and enhance the pace and scale of optimized, systematic and sustainable delivery of PrEP methods. Further research is needed to evaluate use cases of the CRPT.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Columbia University’s ethics committee reviewed and approved the protocol (#AAAU1602). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
-
- Joint United Nations Programme on HIV/AIDS. The urgency of now: AIDS at a crossroads. Geneva; 2024.
-
- The Joint United Nations Programme on HIV/AIDS. The path that ends AIDS: 2023 UNAIDS Global AIDS Update. Geneva: UNAIDS; 2023.
-
- Joint United Nations Programme on HIV/AIDS. Global AIDS update 2021: confronting inequalities – lessons for pandemic responses from 40 years of AIDS. Geneva: Switzerland; 2021.
-
- The World Health Organization. WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection 2021 [cited 2023 July 23]. Available from: https://www.who.int/news/item/26-01-2021-who-recommends-the-dapivirine-v....
-
- The World Health Organization. Guidelines on long-acting injectable cabotegravir for HIV prevention. 2022. - PubMed
MeSH terms
Substances
Grants and funding
- T32AI114398/National Institute of Allergy and Infectious Diseases
- UM1AI069470/National Institute of Allergy and Infectious Diseases
- AID-OAA-A-15-00045 (PROMISE)/U.S. Agency for International Development (USAID)
- 7200AA21CA00011 (MOSAIC)/U.S. Agency for International Development (USAID)
- T32 AI114398/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
